NO20035523D0 - (Pyrido/tieno)-[f]-oksazepin-5-on-derivater - Google Patents

(Pyrido/tieno)-[f]-oksazepin-5-on-derivater

Info

Publication number
NO20035523D0
NO20035523D0 NO20035523A NO20035523A NO20035523D0 NO 20035523 D0 NO20035523 D0 NO 20035523D0 NO 20035523 A NO20035523 A NO 20035523A NO 20035523 A NO20035523 A NO 20035523A NO 20035523 D0 NO20035523 D0 NO 20035523D0
Authority
NO
Norway
Prior art keywords
oxazepin
thieno
pyrido
derivatives
Prior art date
Application number
NO20035523A
Other languages
English (en)
Other versions
NO328710B1 (no
Inventor
Simon James Anthony Grove
Mingqiang Zhang
Julia Adam-Worrall
Robert Gilfillan
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20035523D0 publication Critical patent/NO20035523D0/no
Publication of NO328710B1 publication Critical patent/NO328710B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20035523A 2001-06-14 2003-12-11 (Pyrido/tieno)-[f]-oksazepin-5-on-derivater, farmasoytiske preparater omfattende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdom NO328710B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01202284 2001-06-14
PCT/EP2002/006364 WO2002102808A2 (en) 2001-06-14 2002-06-10 (PYRIDO/THIENO)-[f]-OXAZEPIN-5-ONE DERIVATIVES AS POSITIVE MODULATORS OF THE AMPA RECEPTOR

Publications (2)

Publication Number Publication Date
NO20035523D0 true NO20035523D0 (no) 2003-12-11
NO328710B1 NO328710B1 (no) 2010-05-03

Family

ID=8180476

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035523A NO328710B1 (no) 2001-06-14 2003-12-11 (Pyrido/tieno)-[f]-oksazepin-5-on-derivater, farmasoytiske preparater omfattende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdom

Country Status (25)

Country Link
US (3) US7345036B2 (no)
EP (1) EP1446407A2 (no)
JP (1) JP4435562B2 (no)
KR (1) KR100864267B1 (no)
CN (2) CN101029051B (no)
AR (1) AR034482A1 (no)
AU (1) AU2002320841B2 (no)
BR (1) BR0210307A (no)
CA (1) CA2449215C (no)
CO (1) CO5550448A2 (no)
CZ (1) CZ296217B6 (no)
EC (1) ECSP034890A (no)
HR (1) HRP20031013A2 (no)
HU (1) HUP0400196A3 (no)
IL (2) IL158928A0 (no)
IS (1) IS7042A (no)
MX (1) MXPA03011562A (no)
NO (1) NO328710B1 (no)
NZ (1) NZ529671A (no)
PE (1) PE20030271A1 (no)
PL (1) PL367185A1 (no)
RU (1) RU2286347C2 (no)
SK (1) SK287583B6 (no)
WO (1) WO2002102808A2 (no)
ZA (1) ZA200309096B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200817385A (en) * 2006-07-04 2008-04-16 Organon Nv Heterocyclic derivatives
FR2964969B1 (fr) * 2010-09-16 2012-08-24 Servier Lab Nouveaux derives dihydrobenzoxathiazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1238719A (no) * 1968-11-01 1971-07-07
ATE215079T1 (de) 1992-07-24 2002-04-15 Univ California Arzneimittel, die den durch ampa rezeptoren vermittelten synaptischen respons erhöhen
US6174881B1 (en) * 1995-01-06 2001-01-16 Hoffman-La Roche Inc. Hydroxymethylimidazodiazepines and their esters
US5650409A (en) * 1995-06-02 1997-07-22 Cortex Pharmaceuticals, Inc. Benzoyl piperidines/pyrrolidines for enhancing synaptic response
US5736543A (en) * 1996-04-03 1998-04-07 The Regents Of The University Of California Benzoxazines for enhancing synaptic response
DE69831446T2 (de) 1997-06-09 2006-06-14 Pfizer Prod Inc Chinazolin-4-on AMPA Antagonisten
US5985871A (en) 1997-12-24 1999-11-16 Cortex Pharmaceuticals, Inc. Benzoxazine compounds for enhancing synaptic response
EP1071426A2 (en) 1998-02-18 2001-01-31 Neurosearch A/S Novel compounds and their use as positive ampa receptor modulators
US6124278A (en) 1998-04-03 2000-09-26 The Regents Of The University Of California Acylbenzoxazines for enhancing synaptic response
DE60035591D1 (de) 1999-05-12 2007-08-30 Us Health Thiazepin-hemmer von hiv-1 integrase
TWI232863B (en) 2001-06-11 2005-05-21 Akzo Nobel Nv Benzoxazepine derivatives

Also Published As

Publication number Publication date
IS7042A (is) 2003-11-17
US8034804B2 (en) 2011-10-11
IL158928A (en) 2008-11-26
US20090163473A1 (en) 2009-06-25
RU2004100702A (ru) 2005-06-10
CN101029051B (zh) 2010-06-09
EP1446407A2 (en) 2004-08-18
US20080262221A1 (en) 2008-10-23
WO2002102808A3 (en) 2003-03-20
MXPA03011562A (es) 2004-03-18
HUP0400196A2 (hu) 2004-07-28
US7566778B2 (en) 2009-07-28
ECSP034890A (es) 2004-01-28
PL367185A1 (en) 2005-02-21
SK287583B6 (sk) 2011-03-04
PE20030271A1 (es) 2003-03-19
KR20040007703A (ko) 2004-01-24
JP4435562B2 (ja) 2010-03-17
CN1255413C (zh) 2006-05-10
CN101029051A (zh) 2007-09-05
CZ20033392A3 (en) 2004-05-12
HRP20031013A2 (hr) 2005-10-31
US7345036B2 (en) 2008-03-18
JP2005500301A (ja) 2005-01-06
IL158928A0 (en) 2004-05-12
CA2449215A1 (en) 2002-12-27
CN1516701A (zh) 2004-07-28
CZ296217B6 (cs) 2006-02-15
SK15262003A3 (sk) 2004-05-04
WO2002102808A2 (en) 2002-12-27
NO328710B1 (no) 2010-05-03
CA2449215C (en) 2011-03-22
AR034482A1 (es) 2004-02-25
CO5550448A2 (es) 2005-08-31
RU2286347C2 (ru) 2006-10-27
AU2002320841B2 (en) 2008-02-28
HUP0400196A3 (en) 2007-05-02
ZA200309096B (en) 2005-02-21
BR0210307A (pt) 2004-07-13
US20040220175A1 (en) 2004-11-04
NZ529671A (en) 2005-10-28
KR100864267B1 (ko) 2008-10-20

Similar Documents

Publication Publication Date Title
MA27043A1 (fr) Azaindoles
PT1406628E (pt) Derivados de tera-hidroquinolina
NO20042755L (no) Amidsubstituerte imidazopyridiner
CY2014018I2 (el) Kαρβαμιδο - υποκατεστημενες πυραζολοπυριδινες
PT1257276E (pt) Derivados de azaindole antivirais
NO20023828L (no) Pyrimidin-4-on derivater som LDL-PLA2 inhibitorer
NO20054330D0 (no) 8-substituerte-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
NO20054331D0 (no) Substituerte-8-perfluoralkyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
ATE312827T1 (de) 3-substituierte-4-pyrimidonderivate
NO20032453L (no) Substituerte imidazopyridiner
ZA200309522B (en) Substituted cyclohexane-1-4diamine derivatives
DE60214428D1 (de) 1, 4-dihydro-1, 4-diphenylpyridin-derivate
DK1412328T3 (da) Dolastatin-10-derivater
EE200300447A (et) Asendatud bensofuraan-2-karboksamiidide derivaadid
EP1643987A4 (en) PODOPHYLLOTOXIN DERIVATIVES
HK1068607A1 (en) Phenylalkyloxy-phenyl derivatives
HUP0303186A3 (en) 4-aminobenzopyran derivatives
DE60223031D1 (de) Arylpiperazin gebundene tetrahydroindolonderivate
ATE382601T1 (de) Substituierte 4-aminocyclohexanolderivate
EP1364954A4 (en) Dicarba closo DODECARBORANDERIVATE
IS7042A (is) (Pýridó/þíenó)-[f]-oxasepín-5-on afleiður
DE60202381D1 (de) Paroxetin-n-formyl-derivate
ATE382628T1 (de) Tetrahydrobenzfluorenderivate
GB0129215D0 (en) Trioxane derivatives
DE50104434D1 (de) Lactam-substituierte pyrazolopyridinderivate

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees